TauRx Alzheimer's drug fails in large study; some benefit seen

CHICAGO, July 27 (Reuters) - TauRx Pharmaceuticals'

experimental Alzheimer's drug LMTX failed to improve cognitive

and functional skills in patients with mild to moderate

Alzheimer's disease, a...

Read more